NONPHARMACOLOGICAL THERAPY OF CORONARY HEART DISEASE: THE ROLE AND PLACE OF HYPERBARIC OXYGENATION (literature review)
https://doi.org/10.51523/2708-6011.2012-9-1-5
Abstract
The application of HBO in patients with acute (infarction of myocardium, instable angina) and chronic forms of ischemic heart disease proved itself to be a safe and effective treatment method, which made it possible to increase survival rate from 90,4 % in the control group up to 97,1 % in the main group by the results of the five-year retrospective study, р = 0,001. The maximum efficacy of HBO in «small» doses of hyperoxia was observed in patients with acute and chronic forms of CHD when coronary revascularization was impossible, which revealed an increase in the survival rate from 88,7 % in the control group to 96.3% in the main group, p = 0,004.
References
1. Беленков, Ю. Н. Кардиология. Национальное руководство / Ю. Н. Беленков, Р. Г. Оганов. - М.: Геотар-Медиа, 2008. - 1232 с.
2. Бокерия, Л. А. Хирургическое лечение больных ИБС с поражением брахиоцефальных артерий / Л. А. Бокерия, В. А. Бухарин, В. С. Работников. - М.: НЦХ им. Бакулева РАМН, 2006. - 232 с.
3. Гипербарическая медицина: практическое руководство / под ред. Д. Матье; пер. с англ. - М.: БИНОМ. Лаборатория знаний, 2009. - 720 с.
4. Доценко, Э. А. Частота повторного инфаркта миокарда и двухлетняя выживаемость больных острым инфарктом миокарда при применении гипербарической оксигенации / Э. А. Доценко, Д. П. Саливончик // Медицинская панорама. - 2006. - № 11. - С. 46-49.
5. Митьковская, Н. П. Инфаркт миокарда у больных метабо-лическим синдромом / Н. П. Митьковская, Т. В. Статкевич // Медицинский журнал. - 2009. - № 2. - С. 8-12.
6. Мрочек, А. Г. Итоги работы кардиологической службы Республики Беларусь в 2009 году и задачи на 2010 год / А. Г. Мрочек, С. А. Дубень, Ф. Ф. Ермолкевич // Кардиология в Беларуси. - 2010. - № 2(9). - С. 3-16.
7. Островский, Ю. П. Хирургия сердца / Ю. П. Островский. - М.: Мед. лит, 2007. - 576. с.
8. Показания к проведению коронарной ангиопластики: инструкция по применению / Ю. П. Петров [и др.]. - Минск: Доктор-Дизайн, 2010. - 28 с.
9. Саливончик, Д. П. Отдаленные результаты применения гипербарической оксигенации при лечении острого инфаркта миокарда / Д. П. Саливончик, Э. А. Доценко, В. И. Козыро // Гипербарическая физиология и медицина. - 2006. - № 4. - С. 11-18.
10. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction / E. M. Antman [et al.] // Circulation. - 2004. - Vol. 110. - P. 588-636.
11. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients acute myocardial infarction / M. Dekleva [et al.] // Am. Heart J. - 2004. - Vol. 148. - P. 4.
12. Benefit of early invasive therapy in acute coronary syndromes a meta-analysis of contemporary randomized clinical trials / A. A. Bavry [et al.] // J. Am. Coll. Cardiol. - 2006. - Vol. 48. - P. 1319-1325.
13. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review / W. D. Weaver [et al.] // JAMA. - 1997. - Vol. 278 (23). - P. 2093-2098.
14. Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome - the British Heart Foundation RITA 3 randomized trial / K. A. Fox [et al.] // Lancet. - 2005. - Vol. 366. - P. 914-920.
15. Hyperbaric oxygen and thrombolysis in myocardial infarction: the ‘HOT Ml’ randomized multicenter study / Y. Stavitsky [et al.] // Cardiology. - 1998. - Vol. 90, № 2. - P. 131-136.
16. Hyperbaric oxygen therapy for acute coronary syndrome / M. Bennett [et al.] // Cochrane Database Syst. Rev. - 2005. - Vol. 18(2). - CD004818.
17. Hyperbaric oxygen therapy for acute coronary syndrome / M. Bennett [et al.] // Cochrane Database Syst. Rev. - 2011. - Vol. 1. - CD004819.
18. Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions. Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for AMI or unstable angina pectoris / M. Sharifi [et al.] // Am. J. Cardiol. - 2004. - Vol. 93(12). - P. 1533-1535.
19. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantention / P. Canibusa [et al.] // Metab. Clin. Exper. - 2008. - Vol. 57. - P. 593-597.
20. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis / K. C. Allman [et al.] // J. Am. Coll. Cardiol. - 2002. - Vol. 3. - P. 1151.
21. Outcomes of Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention and Medical Therapy for Multivessel Disease with and without Left Ventricular Dysfunction / E. B. Amitra [et al.] // Cardiology. - 2004. - Vol. 101. - P. 21-28.
22. Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients / S. Capewell [et al.] // Heart. - 2006. - Vol. 92. - P. 521-523.
23. Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trial / S. R. Mehta [et al.] // J.A.M.A. - 2005. - Vol. 293. - P. 2908-2917.
24. Stenestrand, U. Long-term outcome of primary percutaneous coronary intervention vs. prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction / U. Stenestrad, J. Lindback, L. Wallentin // J.A.M.A. - 2006. - Vol. 296. - P. 1749-1756.
25. Strategies for reducing the door-to-balloon time in acute myocardial infarction / E. H. Bradley [et al.] // N. Engl. J. Med. - 2006. - Vol. 355, № 2. - P. 2308-2320.
26. The BARI Investigators Seven-year outcome in the Bypass Angioplasty revascularization Investigation (BARI) by treatment and diabetic status // J. Am. Coll. Cardiol. - 2000. - Vol. 35. - P. 1122-1129.
27. Tsui, W. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs / W. Tsui, K. Pierre, D. Massel // Can. J. Cardiol. - 2005. - Vol. 21(5). - P. 423-431.
28. Tubago, M. ST-segment elevation myocardial infarction management in Europe / M. Tubago, A. Sonia Petronio // J. Cardiovasc. Med. - 2009. - Vol. 10, Suppl. 1. - P. 3-6.
29. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction: result from the STRATEGY study / M. Valgimigli [et al.] // J. Am. Coll. Cardiol. - 2007. - P. 50-138.
30. Yusuf, S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) case-control stude / S. Yusuf, S. Hawken, S. Ounpuu // Lancet. - 2004. - Vol. 364. - P. 937-952.
Review
For citations:
Salivonchyk D.P. NONPHARMACOLOGICAL THERAPY OF CORONARY HEART DISEASE: THE ROLE AND PLACE OF HYPERBARIC OXYGENATION (literature review). Health and Ecology Issues. 2012;(1):27-36. (In Russ.) https://doi.org/10.51523/2708-6011.2012-9-1-5
Views: 258
Email this article 